BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 32299765)

  • 21. Minichromosome maintenance 2 (MCM2) is a new prognostic proliferative marker in Wilms tumour.
    Taran K; Sitkiewicz A; Andrzejewska E; Kobos J
    Pol J Pathol; 2011; 62(2):84-8. PubMed ID: 21866463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer.
    Zhu X; Liang R; Lan T; Ding D; Huang S; Shao J; Zheng Z; Chen T; Huang Y; Liu J; Pathak JL; Wei H; Wei B
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36104099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preliminary observations regarding the expression of collagen triple helix repeat-containing 1 is an independent prognostic factor for Wilms' tumor.
    Qi C; Hu Y; Yang F; An H; Zhang J; Jin H; Guo F
    J Pediatr Surg; 2016 Sep; 51(9):1501-6. PubMed ID: 27230801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumour-associated macrophages: Relation with progression and invasiveness, and assessment of M1/M2 macrophages in canine mammary tumours.
    Monteiro LN; Rodrigues MA; Gomes DA; Salgado BS; Cassali GD
    Vet J; 2018 Apr; 234():119-125. PubMed ID: 29680383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. M2 subtype tumor associated macrophages (M2-TAMs) infiltration predicts poor response rate of immune checkpoint inhibitors treatment for prostate cancer.
    JiaWei Z; ChunXia D; CunDong L; Yang L; JianKun Y; HaiFeng D; Cheng Y; ZhiPeng H; HongYi W; DeYing L; ZhiJian L; Xiao X; QiZhao Z; KangYi X; WenBing G; Ming X; JunHao Z; JiMing B; ShanChao Z; MingKun C
    Ann Med; 2021 Dec; 53(1):730-740. PubMed ID: 34032524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. M1
    Garrido-Martin EM; Mellows TWP; Clarke J; Ganesan AP; Wood O; Cazaly A; Seumois G; Chee SJ; Alzetani A; King EV; Hedrick CC; Thomas G; Friedmann PS; Ottensmeier CH; Vijayanand P; Sanchez-Elsner T
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32699181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry.
    Rakaee M; Busund LR; Jamaly S; Paulsen EE; Richardsen E; Andersen S; Al-Saad S; Bremnes RM; Donnem T; Kilvaer TK
    Neoplasia; 2019 Mar; 21(3):282-293. PubMed ID: 30743162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients.
    Hwang I; Kim JW; Ylaya K; Chung EJ; Kitano H; Perry C; Hanaoka J; Fukuoka J; Chung JY; Hewitt SM
    J Transl Med; 2020 Nov; 18(1):443. PubMed ID: 33228719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumour-associated macrophages are associated with poor prognosis and programmed death ligand 1 expression in oesophageal cancer.
    Yagi T; Baba Y; Okadome K; Kiyozumi Y; Hiyoshi Y; Ishimoto T; Iwatsuki M; Miyamoto Y; Yoshida N; Watanabe M; Komohara Y; Baba H
    Eur J Cancer; 2019 Apr; 111():38-49. PubMed ID: 30822683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic relevance of preoperative transcatheter arterial chemoembolization (TACE) and PCNA/VEGF expression in patients with Wilms' tumour.
    Liu WG; Gu WZ; Zhou YB; Tang HF; Li MJ; Ma WX
    Eur J Clin Invest; 2008 Dec; 38(12):931-8. PubMed ID: 19021718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Staging problems in the pre-operative chemotherapy of Wilms' tumour.
    Zoeller G; Pekrun A; Lakomek M; Ringert RH
    Br J Urol; 1995 Oct; 76(4):501-3. PubMed ID: 7551893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relapse-associated variables in stage I favorable histology Wilms' tumor. A report of the National Wilms' Tumor Study.
    Weeks DA; Beckwith JB; Luckey DW
    Cancer; 1987 Sep; 60(6):1204-12. PubMed ID: 3040208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis.
    Yuan X; Zhang J; Li D; Mao Y; Mo F; Du W; Ma X
    Gynecol Oncol; 2017 Oct; 147(1):181-187. PubMed ID: 28698008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wilms' tumor at the Children's Hospital of Eastern Ontario: 1990-2001.
    Pianezza ML; Rubin S; Bass J; Chou S; Pike JG; Leonard MP
    Can J Urol; 2004 Feb; 11(1):2151-6. PubMed ID: 15003157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Wilms' tumour of unfavorable histology--results of treatment with the SIOP 93-01 protocol at the Gdańsk centre. Preliminary report].
    Stefanowicz J; Sierota D; Balcerska A; Stoba C
    Med Wieku Rozwoj; 2004; 8(2 Pt 1):197-200. PubMed ID: 15738594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of Children with Wilms' Tumor in Developing Countries.
    Bahoush G; Saeedi E
    J Med Life; 2020; 13(4):484-489. PubMed ID: 33456596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics and outcome of stage II and III non-anaplastic Wilms' tumour treated according to the SIOP trial and study 93-01.
    Graf N; van Tinteren H; Bergeron C; Pein F; van den Heuvel-Eibrink MM; Sandstedt B; Schenk JP; Godzinski J; Oldenburger F; Furtwängler R; de Kraker J
    Eur J Cancer; 2012 Nov; 48(17):3240-8. PubMed ID: 22795263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database.
    Brok J; Lopez-Yurda M; Tinteren HV; Treger TD; Furtwängler R; Graf N; Bergeron C; van den Heuvel-Eibrink MM; Pritchard-Jones K; Olsen ØE; de Camargo B; Verschuur A; Spreafico F
    Lancet Oncol; 2018 Aug; 19(8):1072-1081. PubMed ID: 29960848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wilms' tumor: a 10 year retrospective study.
    Seyed-Ahadi MM; Khaleghnejad-Tabari A; Mirshemirani A; Sadeghian N; Amonollahi O
    Arch Iran Med; 2007 Jan; 10(1):65-9. PubMed ID: 17198457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pilot study of F(18)-Fluorodeoxyglucose Positron Emission Tomography/computerised tomography in Wilms' tumour: correlation with conventional imaging, pathology and immunohistochemistry.
    Begent J; Sebire NJ; Levitt G; Brock P; Jones KP; Ell P; Gordon I; Anderson J
    Eur J Cancer; 2011 Feb; 47(3):389-96. PubMed ID: 21074411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.